Tenet Healthcare (THC) At $17.61 Forms Bottom; Gridsum Holding Ads (GSUM) Shorts Increased By 17.08%

Tenet Healthcare Corporation (THC) formed multiple bottom with $16.20 target or 8.00% below today’s $17.61 share price. Tenet Healthcare Corporation (THC) has $1.78 billion valuation. The stock decreased 3.56% or $0.65 during the last trading session, reaching $17.61. About 1.93M shares traded. Tenet Healthcare Corporation (NYSE:THC) has declined 36.81% since February 6, 2017 and is downtrending. It has underperformed by 53.51% the S&P500.

Gridsum Holding Ads (NASDAQ:GSUM) had an increase of 17.08% in short interest. GSUM’s SI was 904,800 shares in February as released by FINRA. Its up 17.08% from 772,800 shares previously. With 504,800 avg volume, 2 days are for Gridsum Holding Ads (NASDAQ:GSUM)’s short sellers to cover GSUM’s short positions. The SI to Gridsum Holding Ads’s float is 5.73%. The stock decreased 8.45% or $1.05 during the last trading session, reaching $11.37. About 796,451 shares traded or 34.64% up from the average. Gridsum Holding Inc. (NASDAQ:GSUM) has 0.00% since February 6, 2017 and is . It has underperformed by 16.70% the S&P500.

Gridsum Holding Inc. provides data analysis software for multinational and domestic enterprises, and government agencies in China. The company has market cap of $349.47 million. The Company’s proprietary distributed data architecture allows its clients to collect and analyze vast amounts of information; and Gridsum Big Data platform performs multi-dimensional correlation analysis and analyzes complex real-time events. It currently has negative earnings. The firm offers Web Dissector to analyze customer Websites by monitoring and analyzing key performance indicators; Mobile Dissector to understand mobile app user activity; SEM Dissector for search engine marketing; SEO Dissector, a search engine optimization tool; Ad Dissector, an advertisement performance monitoring and optimization product; Contribution Dissector to evaluate the performance of advertising campaigns; Audience Dissector, an audience analysis product; Recommendation Engine, a data driven content recommendation solution.

Investors sentiment increased to 1.33 in Q3 2017. Its up 0.08, from 1.25 in 2017Q2. It increased, as 33 investors sold Tenet Healthcare Corporation shares while 57 reduced holdings. 41 funds opened positions while 79 raised stakes. 122.38 million shares or 7.67% more from 113.66 million shares in 2017Q2 were reported. Grantham Mayo Van Otterloo And Co Ltd Co holds 238,900 shares or 0.02% of its portfolio. Stonehill Capital Lc reported 225,033 shares. Swiss State Bank reported 0% of its portfolio in Tenet Healthcare Corporation (NYSE:THC). Commonwealth Bank Of Australia reported 40,300 shares. Barclays Public Ltd Com holds 0% or 89,278 shares in its portfolio. Grp One Trading L P invested 0% of its portfolio in Tenet Healthcare Corporation (NYSE:THC). Illinois-based Northern Tru has invested 0.01% in Tenet Healthcare Corporation (NYSE:THC). Pomelo Capital Ltd Llc reported 0.09% of its portfolio in Tenet Healthcare Corporation (NYSE:THC). Invesco holds 0.01% of its portfolio in Tenet Healthcare Corporation (NYSE:THC) for 1.01 million shares. Oakworth Capital holds 0% or 34 shares in its portfolio. Camber Capital holds 5.75 million shares. Aqr Cap Mngmt Ltd Liability Co has 0% invested in Tenet Healthcare Corporation (NYSE:THC) for 12,860 shares. 48,606 are held by Hap Trading Llc. Landscape Capital Ltd holds 0.07% of its portfolio in Tenet Healthcare Corporation (NYSE:THC) for 41,621 shares. Cibc World Mkts holds 0% or 18,816 shares.

Analysts await Tenet Healthcare Corporation (NYSE:THC) to report earnings on February, 26. They expect $1.29 earnings per share, up 2,050.00% or $1.23 from last year’s $0.06 per share. THC’s profit will be $130.25M for 3.41 P/E if the $1.29 EPS becomes a reality. After $-0.17 actual earnings per share reported by Tenet Healthcare Corporation for the previous quarter, Wall Street now forecasts -858.82% EPS growth.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: